ADMA

Adma Biologics Stock Analysis

AI Rating

Great
  • Quality9/10
  • Growth↑ 9/10
  • Momentum↓ 3/10
Adma Biologics sales and earnings growth
ADMA Growth
Great
  • Revenue Y/Y↑ 27.62%
  • EPS Y/Y↑ 203.45%
  • FCF Y/Y↓ -48.70%
Adma Biologics gross and profit margin trends
ADMA Profitability
Great
  • Gross margin ↑ 54.70%
  • EPS margin↑ 42.90%
  • ROIC↑ 35.70%
Adma Biologics net debt vs free cash flow
ADMA Risk
Great
  • Debt / Equity↓ 0.2
  • Debt / FCF↓ 0.3
  • Interest coverage↑ 19.6

Adma Biologics stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗